1188 related articles for article (PubMed ID: 28978633)
1. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H
Szabo C; Papapetropoulos A
Pharmacol Rev; 2017 Oct; 69(4):497-564. PubMed ID: 28978633
[TBL] [Abstract][Full Text] [Related]
2. A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?
Cao X; Ding L; Xie ZZ; Yang Y; Whiteman M; Moore PK; Bian JS
Antioxid Redox Signal; 2019 Jul; 31(1):1-38. PubMed ID: 29790379
[No Abstract] [Full Text] [Related]
3. Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.
Druzhyna N; Szczesny B; Olah G; Módis K; Asimakopoulou A; Pavlidou A; Szoleczky P; Gerö D; Yanagi K; Törö G; López-García I; Myrianthopoulos V; Mikros E; Zatarain JR; Chao C; Papapetropoulos A; Hellmich MR; Szabo C
Pharmacol Res; 2016 Nov; 113(Pt A):18-37. PubMed ID: 27521834
[TBL] [Abstract][Full Text] [Related]
4. Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs.
Cirino G; Szabo C; Papapetropoulos A
Physiol Rev; 2023 Jan; 103(1):31-276. PubMed ID: 35435014
[TBL] [Abstract][Full Text] [Related]
5. A critical role for cystathionine-β-synthase in hydrogen sulfide-mediated hypoxic relaxation of the coronary artery.
Donovan J; Wong PS; Roberts RE; Garle MJ; Alexander SPH; Dunn WR; Ralevic V
Vascul Pharmacol; 2017 Aug; 93-95():20-32. PubMed ID: 28552745
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological induction of mesenchymal-epithelial transition via inhibition of H2S biosynthesis and consequent suppression of ACLY activity in colon cancer cells.
Ascenção K; Dilek N; Augsburger F; Panagaki T; Zuhra K; Szabo C
Pharmacol Res; 2021 Mar; 165():105393. PubMed ID: 33484818
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide in pharmacology and medicine--An update.
Bełtowski J
Pharmacol Rep; 2015 Jun; 67(3):647-58. PubMed ID: 25933982
[TBL] [Abstract][Full Text] [Related]
8. Development and Application of Carbonyl Sulfide-Based Donors for H
Levinn CM; Cerda MM; Pluth MD
Acc Chem Res; 2019 Sep; 52(9):2723-2731. PubMed ID: 31390174
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide: An endogenous regulator of the immune system.
Dilek N; Papapetropoulos A; Toliver-Kinsky T; Szabo C
Pharmacol Res; 2020 Nov; 161():105119. PubMed ID: 32781284
[TBL] [Abstract][Full Text] [Related]
10. Potential role of the 3-mercaptopyruvate sulfurtransferase (3-MST)-hydrogen sulfide (H
Augsburger F; Szabo C
Pharmacol Res; 2020 Apr; 154():104083. PubMed ID: 30500457
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
Wang XH; Wang F; You SJ; Cao YJ; Cao LD; Han Q; Liu CF; Hu LF
Cell Signal; 2013 Nov; 25(11):2255-62. PubMed ID: 23872072
[TBL] [Abstract][Full Text] [Related]
12. Annexin A1 mediates hydrogen sulfide properties in the control of inflammation.
Brancaleone V; Mitidieri E; Flower RJ; Cirino G; Perretti M
J Pharmacol Exp Ther; 2014 Oct; 351(1):96-104. PubMed ID: 25077524
[TBL] [Abstract][Full Text] [Related]
13. Phosphinodithioate and Phosphoramidodithioate Hydrogen Sulfide Donors.
Whiteman M; Perry A; Zhou Z; Bucci M; Papapetropoulos A; Cirino G; Wood ME
Handb Exp Pharmacol; 2015; 230():337-63. PubMed ID: 26162843
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide: a gasotransmitter of clinical relevance.
Vandiver M; Snyder SH
J Mol Med (Berl); 2012 Mar; 90(3):255-63. PubMed ID: 22314625
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
[TBL] [Abstract][Full Text] [Related]
16. The effect of hydrogen sulfide-releasing naproxen (ATB-346) versus naproxen on formation of stress-induced gastric lesions, the regulation of systemic inflammation, hypoxia and alterations in gastric microcirculation.
Magierowski M; Magierowska K; Surmiak M; Hubalewska-Mazgaj M; Kwiecien S; Wallace JL; Brzozowski T
J Physiol Pharmacol; 2017 Oct; 68(5):749-756. PubMed ID: 29375050
[TBL] [Abstract][Full Text] [Related]
17. The novel H
Testai L; Marino A; Piano I; Brancaleone V; Tomita K; Di Cesare Mannelli L; Martelli A; Citi V; Breschi MC; Levi R; Gargini C; Bucci M; Cirino G; Ghelardini C; Calderone V
Pharmacol Res; 2016 Nov; 113(Pt A):290-299. PubMed ID: 27616550
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of cystathionine-β-synthase inhibition by disulfiram: The role of bis(N,N-diethyldithiocarbamate)-copper(II).
Zuhra K; Panagaki T; Randi EB; Augsburger F; Blondel M; Friocourt G; Herault Y; Szabo C
Biochem Pharmacol; 2020 Dec; 182():114267. PubMed ID: 33035509
[TBL] [Abstract][Full Text] [Related]
19. Interaction between endogenous carbon monoxide and hydrogen sulfide in the mechanism of gastroprotection against acute aspirin-induced gastric damage.
Magierowski M; Magierowska K; Hubalewska-Mazgaj M; Adamski J; Bakalarz D; Sliwowski Z; Pajdo R; Kwiecien S; Brzozowski T
Pharmacol Res; 2016 Dec; 114():235-250. PubMed ID: 27825819
[TBL] [Abstract][Full Text] [Related]
20. Acute acrylonitrile exposure inhibits endogenous H
Yang B; Zhao W; Yin C; Bai Y; Wang S; Xing G; Li F; Bian J; Aschner M; Cai J; Shi H; Lu R
Toxicology; 2021 Mar; 451():152685. PubMed ID: 33486070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
